HDAC6 and glioblastoma: In parallel, HDAC6’s role in promoting neoangiogenesis and in regulating inflammation and cell migration indicates that deregulation of HDAC6 activity may also influence pathway derangement in mesenchymal GBM cells [4,212,213].